Cigna Corp vs Teucrium Soybean Fund — how do they compare? Cigna Corp trades at $304.49 (market cap $80.25B), while Teucrium Soybean Fund trades at $25.5. The key difference: Cigna Corp pays a 2.06% dividend while Teucrium Soybean Fund pays none, and Teucrium Soybean Fund is trading nearer its 52-week high, Cigna Corp nearer its low. Which is the better fit depends on your goals.
| CI | SOYB | |
|---|---|---|
Market Cap | $80.25B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $311.00 | $25.36 |
52-Week Low | $244.41 | $21.07 |
Enterprise Value | $103.35B | — |
Dividend Yield | 2.06% | — |
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
SOYB trades at $25.33, up 0.64% on the day, with a bullish technical outlook from moving averages but neutral oscillators. The stock lacks disclosed financial ratios, and recent news highlights potential tailwinds from agricultural trade developments, including China's pledge to buy $17 billion of U.S. crops annually through 2028, which could benefit related sectors.
The stock's upside is supported by positive technical momentum and sector-specific catalysts, though the absence of fundamental data limits valuation clarity. Risks include reliance on agricultural market stability and potential volatility from commodity price swings, requiring careful assessment of upcoming earnings and guidance.
Trailing returns across standard periods
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →